Dr.med. Irina Bergamin
Gastroenterology/Hepatology · Dept. I
MSD MK1308A-004
Jul 3, 2021Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma
Clinical Studies - Jul 3, 2021 - Dec 3, 2022
Automatically Closed
Project leader: Semela David
Members: Stillhard Roman, Bergamin Irina
Evaluation of Controlled Attenuated Parameter (CAP) for Assessment of Liver Steatosis in an Unselected Population: a Single Center Real Life Experience
Dec 16, 2015Background & Aims: Controlled attenuated parameter (CAP) is a new parameter to assess steatosis of the liver, which is obtained together with elastography. Our aim was to assess the performance of CAP in an unselected population with different liver...
Clinical Studies - Dec 16, 2015 - Dec 16, 2017
Completed
Project leader: Baumeler Stephan
Members: Semela David, Bergamin Irina, Jochum Wolfram, Neuweiler Jörg
Liver metastasis in colorectal carcinoma: Accuracy of Contrast-enhanced ultrasound (CEUS) in comparison with computertomography on new diagnosed CRC with impact on therapy strategy?
Dec 1, 2015Background: Up to 20% of liver metastasis could be missed by CT according to the oncological staging in colorectal carcinoma Primary endpoint: Detection of colorectal liver metastasis (CRLM) – comparison of CEUS with CT (hypothesis CEUS with better s...
Clinical Studies - Dec 1, 2015 - Nov 1, 2018
Automatically Closed
Project leader: Sawatzki Mikael
Members: Alfter Christine, Semela David, Gueller Ulrich, Horber Daniel, Bergamin Irina